Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure
On January 20, 2017, Simulations Plus, Inc., a California
corporation (the Company), issued a press release announcing that
its board of directors has declared a quarterly cash dividend of
$0.05 per share of common stock, payable on February 6, 2017 to
shareholders of record on January 30, 2017.
A copy of press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
The information contained in this Current Report on Form 8-K
shall not be deemed to be filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that section, nor
shall such information be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended (the
Securities Act), or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The
information set forth in this Current Report on Form 8-K shall
not be deemed an admission as to the materiality of any
information in this report on Current Report on Form 8-K that is
required to be disclosed solely to satisfy the requirements of
Regulation FD.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This Current Report on Form 8-K may contain forward-looking
statements that are made to the safe harbor provisions of Section
21E of the Exchange Act. The forward-looking statements in this
Current Report on Form 8-K are not historical facts, do not
constitute guarantees of future performance and are based on
numerous assumptions which, while believed to be reasonable, may
not prove to be accurate. Any forward-looking statements in this
Current Report on Form 8-K do not constitute guarantees of future
performance and involve a number of factors that could cause
actual results to differ materially, including risks more fully
described in our most recently filed Quarterly Report on Form
10-Q and Annual Report on Form 10-K. The Company assumes no
obligation to update any forward-looking information contained in
this Current Report or with respect to the announcements
described herein.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits
| 99.1 | Press release issued on January 20, 2017. |
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
About Simulations Plus, Inc. (NASDAQ:SLP)
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs. Simulations Plus, Inc. (NASDAQ:SLP) Recent Trading Information
Simulations Plus, Inc. (NASDAQ:SLP) closed its last trading session down -0.02 at 9.88 with 31,206 shares trading hands.